These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12466330)

  • 1. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.
    Hirshberg B; Mog S; Patterson N; Leconte J; Harlan DM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5424-9. PubMed ID: 12466330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
    Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
    Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
    Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
    Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?
    Desai NM; Goss JA; Deng S; Wolf BA; Markmann E; Palanjian M; Shock AP; Feliciano S; Brunicardi FC; Barker CF; Naji A; Markmann JF
    Transplantation; 2003 Dec; 76(11):1623-5. PubMed ID: 14702535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site.
    Hirshberg B; Montgomery S; Wysoki MG; Xu H; Tadaki D; Lee J; Hines K; Gaglia J; Patterson N; Leconte J; Hale D; Chang R; Kirk AD; Harlan DM
    Diabetes; 2002 Jul; 51(7):2135-40. PubMed ID: 12086943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
    Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
    Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.
    Abdulreda MH; Berman DM; Shishido A; Martin C; Hossameldin M; Tschiggfrie A; Hernandez LF; Hernandez A; Ricordi C; Parel JM; Jankowska-Gan E; Burlingham WJ; Arrieta-Quintero EA; Perez VL; Kenyon NS; Berggren PO
    Diabetologia; 2019 May; 62(5):811-821. PubMed ID: 30701283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.
    Toso C; Baertschiger R; Morel P; Bosco D; Armanet M; Wojtusciszyn A; Badet L; Philippe J; Becker CD; Hadaya K; Majno P; Bühler L; Berney T;
    Am J Transplant; 2006 May; 6(5 Pt 1):1049-58. PubMed ID: 16611343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
    Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
    Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
    Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
    N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
    Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
    Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
    O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
    Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascularized islet-cell transplantation in miniature swine. I. Preparation of vascularized islet kidneys.
    Kumagai N; O'Neil JJ; Barth RN; LaMattina JC; Utsugi R; Moran SG; Yamamoto S; Vagefi PA; Kitamura H; Kamano C; Sachs DH; Yamada K
    Transplantation; 2002 Nov; 74(9):1223-30. PubMed ID: 12451257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1β and TNF-α.
    Matsumoto S; Takita M; Chaussabel D; Noguchi H; Shimoda M; Sugimoto K; Itoh T; Chujo D; SoRelle J; Onaca N; Naziruddin B; Levy MF
    Cell Transplant; 2011; 20(10):1641-7. PubMed ID: 21396171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fate of Allogeneic Pancreatic Islets following Intraportal Transplantation: Challenges and Solutions.
    Li X; Meng Q; Zhang L
    J Immunol Res; 2018; 2018():2424586. PubMed ID: 30345316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Focus on Islets of Langerhans transplantation].
    Bayle F
    Presse Med; 2001 Sep; 30(24 Pt 2):19-20. PubMed ID: 11577579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell transplantation.
    Vaithilingam V; Sundaram G; Tuch BE
    Curr Opin Organ Transplant; 2008 Dec; 13(6):633-8. PubMed ID: 19060555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the immunosuppressive regime of Edmonton protocol on the long-term in vitro insulin secretion from islets of two different species and age categories.
    Hyder A; Laue C; Schrezenmeir J
    Toxicol In Vitro; 2005 Jun; 19(4):541-6. PubMed ID: 15826812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates.
    Adams AB; Shirasugi N; Durham MM; Strobert E; Anderson D; Rees P; Cowan S; Xu H; Blinder Y; Cheung M; Hollenbaugh D; Kenyon NS; Pearson TC; Larsen CP
    Diabetes; 2002 Feb; 51(2):265-70. PubMed ID: 11812731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.